[2-(1H-imidazol-4-yl)ethyl]-{4-[2-(methylthio)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]benzyl}amine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: [2-(1H-imidazol-4-yl)ethyl]-{4-[2-(methylthio)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]benzyl}amine
• 英文别名: [2-(1H-imidazol-4-yl)ethyl]({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)amine；2-(1H-imidazol-5-yl)-N-[[4-(2-methylsulfanyl-6-phenylpyrido[2,3-d]pyrimidin-7-yl)phenyl]methyl]ethanamine
• 化学式: C₂₆H₂₄N₆S
• 分子量: 452.583
• InChiKey: HUGJYXBFDDAZEO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  33
• 可旋转键数：
  8
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  105
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  4-[2-(methylthio)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]benzaldehyde 、 组胺 在 三乙酰氧基硼氢化钠 、 溶剂黄146 作用下， 以 1,2-二氯乙烷 为溶剂， 生成 [2-(1H-imidazol-4-yl)ethyl]-{4-[2-(methylthio)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]benzyl}amine
  参考文献：
  名称：

  Development of Pyridopyrimidines as Potent Akt1/2 Inhibitors

  摘要：

  This communication reports a new synthetic route of pyridopyrimidines to facilitate their structural optimization in a library fashion and describes the development of pyridopyrimidines that have excellent enzymatic and cell potency against Akt1 and Akt2. This series also shows a high level of selectivity over other closely related kinases and significantly improved caspase-3 activity with the more optimized compounds. (c) 2008 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmcl.2008.01.054

文献信息

• Inhibitors of Akt Activity
  申请人：Bilodeau Mark T.

  公开号：US20080280899A1

  公开（公告）日：2008-11-13

  The present invention is directed to compounds which contain substituted napthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.

  本发明涉及含有取代萘啶的化合物，其抑制Akt，一种丝氨酸/苏氨酸蛋白激酶的活性。本发明还涉及包含该发明化合物的化疗组合物以及使用该发明化合物治疗癌症的方法。
• US7750151B2
  申请人：——

  公开号：US7750151B2

  公开（公告）日：2010-07-06
• Development of Pyridopyrimidines as Potent Akt1/2 Inhibitors
  作者：Zhicai Wu、John C. Hartnett、Lou Anne Neilson、Ronald G. Robinson、Sheng Fu、Stanley F. Barnett、Deborah Defeo-Jones、Raymond E. Jones、Astrid M. Kral、Hans E. Huber、George D. Hartman、Mark T. Bilodeau

  DOI：10.1016/j.bmcl.2008.01.054

  日期：2008.2

  This communication reports a new synthetic route of pyridopyrimidines to facilitate their structural optimization in a library fashion and describes the development of pyridopyrimidines that have excellent enzymatic and cell potency against Akt1 and Akt2. This series also shows a high level of selectivity over other closely related kinases and significantly improved caspase-3 activity with the more optimized compounds. (c) 2008 Published by Elsevier Ltd.